N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide

C145H114Cl2F22N46O11 — CID 167667485

About N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide

N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide (PubChem CID 167667485) has the molecular formula C145H114Cl2F22N46O11 and a molecular weight of 3165.68 g/mol. Its IUPAC name is N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide.

Molecular Properties

• Compound Name: N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide
• PubChem CID: 167667485
• Molecular Formula: C145H114Cl2F22N46O11
• Molecular Weight: 3165.68 g/mol
• Exact Mass: 3162.88
• IUPAC Name: N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide
• SMILES: Cn1nc(NC(=O)C2(C(=O)Nc3ccc(-c4cnc5cnccn45)c(F)c3)CC2)cc1C(F)(F)F.Cn1nc(NC(=O)C2(C(=O)Nc3ccc(-c4cnc5cnccn45)cc3)CC2)cc1C(C)(F)F.Cn1nc(NC(=O)CNc2ccc(-c3cnc4cnccn34)c(F)c2)cc1C(F)(F)F.Cn1nc(NC(=O)CNc2ccc(-c3cnc4cnccn34)cc2)cc1C(F)(F)F.Cn1nc(NC(=O)COc2ccc(-c3cnn4cccnc34)cc2)cc1C(F)(F)F.O=C(CNc1ccc(-c2cnc3cnccn23)cc1)Nc1cc(C(F)(F)F)c(Cl)cn1.O=C(Nc1ccc(-c2cnc3cnccn23)cc1)C1(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)CC1
• InChI: InChI=1S/C23H16ClF3N6O2.C23H21F2N7O2.C22H17F4N7O2.C20H14ClF3N6O.C19H15F4N7O.C19H16F3N7O.C19H15F3N6O2/c24-16-10-29-18(9-15(16)23(25,26)27)32-21(35)22(5-6-22)20(34)31-14-3-1-13(2-4-14)17-11-30-19-12-28-7-8-33(17)19;1-22(24,25)17-11-18(30-31(17)2)29-21(34)23(7-8-23)20(33)28-15-5-3-14(4-6-15)16-12-27-19-13-26-9-10-32(16)19;1-32-16(22(24,25)26)9-17(31-32)30-20(35)21(4-5-21)19(34)29-12-2-3-13(14(23)8-12)15-10-28-18-11-27-6-7-33(15)18;21-15-8-27-17(7-14(15)20(22,23)24)29-19(31)11-26-13-3-1-12(2-4-13)16-9-28-18-10-25-5-6-30(16)18;1-29-15(19(21,22)23)7-16(28-29)27-18(31)10-25-11-2-3-12(13(20)6-11)14-8-26-17-9-24-4-5-30(14)17;1-28-15(19(20,21)22)8-16(27-28)26-18(30)11-24-13-4-2-12(3-5-13)14-9-25-17-10-23-6-7-29(14)17;1-27-15(19(20,21)22)9-16(26-27)25-17(29)11-30-13-5-3-12(4-6-13)14-10-24-28-8-2-7-23-18(14)28/h1-4,7-12H,5-6H2,(H,31,34)(H,29,32,35);3-6,9-13H,7-8H2,1-2H3,(H,28,33)(H,29,30,34);2-3,6-11H,4-5H2,1H3,(H,29,34)(H,30,31,35);1-10,26H,11H2,(H,27,29,31);2-9,25H,10H2,1H3,(H,27,28,31);2-10,24H,11H2,1H3,(H,26,27,30);2-10H,11H2,1H3,(H,25,26,29)
• InChIKey: SVUWOKCQBSRAQD-UHFFFAOYSA-N
• XLogP: 26.28
• TPSA: 662.53 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 47
• Rotatable Bonds: 36
• Heavy Atoms: 226
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3165.68
LogP ≤ 5	26.28
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	47

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide?

The IUPAC name of N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide (CID 167667485) is N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide.

What is the SMILES notation for N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide?

The canonical SMILES for N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide is Cn1nc(NC(=O)C2(C(=O)Nc3ccc(-c4cnc5cnccn45)c(F)c3)CC2)cc1C(F)(F)F.Cn1nc(NC(=O)C2(C(=O)Nc3ccc(-c4cnc5cnccn45)cc3)CC2)cc1C(C)(F)F.Cn1nc(NC(=O)CNc2ccc(-c3cnc4cnccn34)c(F)c2)cc1C(F)(F)F.Cn1nc(NC(=O)CNc2ccc(-c3cnc4cnccn34)cc2)cc1C(F)(F)F.Cn1nc(NC(=O)COc2ccc(-c3cnn4cccnc34)cc2)cc1C(F)(F)F.O=C(CNc1ccc(-c2cnc3cnccn23)cc1)Nc1cc(C(F)(F)F)c(Cl)cn1.O=C(Nc1ccc(-c2cnc3cnccn23)cc1)C1(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)CC1.

What is the InChIKey of N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide?

The InChIKey is SVUWOKCQBSRAQD-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H16ClF3N6O2.C23H21F2N7O2.C22H17F4N7O2.C20H14ClF3N6O.C19H15F4N7O.C19H16F3N7O.C19H15F3N6O2/c24-16-10-29-18(9-15(16)23(25,26)27)32-21(35)22(5-6-22)20(34)31-14-3-1-13(2-4-14)17-11-30-19-12-28-7-8-33(17)19;1-22(24,25)17-11-18(30-31(17)2)29-21(34)23(7-8-23)20(33)28-15-5-3-14(4-6-15)16-12-27-19-13-26-9-10-32(16)19;1-32-16(22(24,25)26)9-17(31-32)30-20(35)21(4-5-21)19(34)29-12-2-3-13(14(23)8-12)15-10-28-18-11-27-6-7-33(15)18;21-15-8-27-17(7-14(15)20(22,23)24)29-19(31)11-26-13-3-1-12(2-4-13)16-9-28-18-10-25-5-6-30(16)18;1-29-15(19(21,22)23)7-16(28-29)27-18(31)10-25-11-2-3-12(13(20)6-11)14-8-26-17-9-24-4-5-30(14)17;1-28-15(19(20,21)22)8-16(27-28)26-18(30)11-24-13-4-2-12(3-5-13)14-9-25-17-10-23-6-7-29(14)17;1-27-15(19(20,21)22)9-16(26-27)25-17(29)11-30-13-5-3-12(4-6-13)14-10-24-28-8-2-7-23-18(14)28/h1-4,7-12H,5-6H2,(H,31,34)(H,29,32,35);3-6,9-13H,7-8H2,1-2H3,(H,28,33)(H,29,30,34);2-3,6-11H,4-5H2,1H3,(H,29,34)(H,30,31,35);1-10,26H,11H2,(H,27,29,31);2-9,25H,10H2,1H3,(H,27,28,31);2-10,24H,11H2,1H3,(H,26,27,30);2-10H,11H2,1H3,(H,25,26,29).

What are the key properties of N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide?

N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide has a molecular weight of 3165.68 g/mol, XLogP of 26.28, 36 rotatable bonds, 13 hydrogen bond donors, and 47 hydrogen bond acceptors.

Where does this data come from?

All data for N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)acetamide;1-N'-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;1-N'-[5-(1,1-difluoroethyl)-1-methylpyrazol-3-yl]-1-N-(4-imidazo[1,2-a]pyrazin-3-ylphenyl)cyclopropane-1,1-dicarboxamide;2-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;1-N-(3-fluoro-4-imidazo[1,2-a]pyrazin-3-ylphenyl)-1-N'-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]cyclopropane-1,1-dicarboxamide;2-(4-imidazo[1,2-a]pyrazin-3-ylanilino)-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]acetamide;N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(4-pyrazolo[1,5-a]pyrimidin-3-ylphenoxy)acetamide is sourced from PubChem (CID 167667485), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).